NDC 0093-2069

Doxazosin

Doxazosin Mesylate

Doxazosin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Doxazosin Mesylate.

Product ID0093-2069_1147fddf-c4b3-405b-8509-57480349362f
NDC0093-2069
Product TypeHuman Prescription Drug
Proprietary NameDoxazosin
Generic NameDoxazosin Mesylate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-08-06
Marketing CategoryANDA / ANDA
Application NumberANDA075536
Labeler NameTeva Pharmaceuticals USA, Inc.
Substance NameDOXAZOSIN MESYLATE
Active Ingredient Strength2 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0093-2069-01

100 TABLET in 1 BOTTLE (0093-2069-01)
Marketing Start Date2014-08-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0093-2069-19 [00093206919]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA075536
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-08-06
Marketing End Date2019-12-09

NDC 0093-2069-93 [00093206993]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA075536
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-08-06
Marketing End Date2014-08-06

NDC 0093-2069-01 [00093206901]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA075536
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-08-12

NDC 0093-2069-05 [00093206905]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA075536
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-08-06
Marketing End Date2014-08-06

Drug Details

Active Ingredients

IngredientStrength
DOXAZOSIN MESYLATE2 mg/1

OpenFDA Data

SPL SET ID:0aaa68a7-f73b-46d8-860f-a76d96897489
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197628
  • 197625
  • 197627
  • 197626
    • UPC Code
  • 0300932070011
  • 0300932069015
  • 0300932068018
  • 0300932067011

    • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "Doxazosin" or generic name "Doxazosin Mesylate"

    NDCBrand NameGeneric Name
    68071-1889DoxazosinDoxazosin
    68071-4273DoxazosinDoxazosin
    68071-3298DoxazosinDoxazosin
    68071-3331DoxazosinDoxazosin
    68071-3341DoxazosinDoxazosin
    68071-4272DoxazosinDoxazosin
    68084-862DoxazosinDoxazosin
    68084-836DoxazosinDoxazosin
    68084-851DoxazosinDoxazosin
    68382-783DoxazosinDoxazosin
    68382-785DoxazosinDoxazosin
    68382-784DoxazosinDoxazosin
    68382-786DoxazosinDoxazosin
    68645-464DoxazosinDoxazosin
    68645-465DoxazosinDoxazosin
    68645-463DoxazosinDoxazosin
    68788-7149DoxazosinDoxazosin
    68788-7328DoxazosinDoxazosin
    68788-9675DoxazosinDoxazosin
    70518-0839DoxazosinDoxazosin
    70518-1061DoxazosinDoxazosin
    70518-1645DoxazosinDoxazosin
    70518-1560DoxazosinDoxazosin
    70518-1804DoxazosinDoxazosin
    70771-1115DoxazosinDoxazosin
    70771-1114DoxazosinDoxazosin
    70771-1112DoxazosinDoxazosin
    70771-1113DoxazosinDoxazosin
    71335-0309DoxazosinDoxazosin
    71335-0349DoxazosinDoxazosin
    71335-0002DoxazosinDoxazosin
    71610-153DoxazosinDoxazosin
    0615-5536DoxazosinDoxazosin
    0615-6570DoxazosinDoxazosin
    0615-6571DoxazosinDoxazosin
    71610-160DoxazosinDoxazosin
    0615-5537DoxazosinDoxazosin
    71610-043DoxazosinDoxazosin
    0832-0357DoxazosinDoxazosin
    0832-0356DoxazosinDoxazosin
    0832-1359DoxazosinDoxazosin
    0832-1358DoxazosinDoxazosin
    0904-5523DoxazosinDoxazosin
    0904-5524DoxazosinDoxazosin
    0904-5522DoxazosinDoxazosin
    0093-2067DoxazosinDoxazosin
    0093-2068DoxazosinDoxazosin
    0093-2069DoxazosinDoxazosin
    0093-2070DoxazosinDoxazosin
    16729-211DoxazosinDoxazosin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.